التفاصيل البيبلوغرافية
| العنوان: |
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. |
| المؤلفون: |
Maximilian F. Konig1,2,3,4,5, Powell, Mike6, Staedtke, Verena7, Ren-Yuan Bai8, Thomas, David L.9, Fischer, Nicole5, Sakibul Huq8, Khalafallah, Adham M.8, Koenecke, Allison10, Xiong, Ruoxuan11, Mensh, Brett12, Papadopoulos, Nickolas1,2,3, Kinzler, Kenneth W.1,2,3, Vogelstein, Bert1,2,3, Vogelstein, Joshua T.6 jovo@jhu.edu, Athey, Susan13 athey@stanford.edu, Shibin Zhou1,2,3 sbzhou@jhmi.edu, Bettegowda, Chetan1,2,3,8 cbetteg1@jhmi.edu |
| المصدر: |
Journal of Clinical Investigation. Jul2020, Vol. 130 Issue 7, p3345-3347. 3p. |
| مستخلص: |
Medications that target catecholamine-associated inflammation may prevent cytokine storm syndrome associated with COVID-19 and other diseases. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder